VKH
CBMG

Virtu KCG Holdings’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Virtu KCG Holdings’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,487
Closed -$267K – 3925
2015
Q1 		$267K Buy
+8,487
New +$229K 0.01% 2042

Other funds holding CBMG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Virtu KCG Holdings's CBMG Position: Q2 2015 in Review

Virtu KCG Holdings sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q2 2015, closing a stake of 8,487 shares — an estimated $267K sold.

Virtu KCG Holdings first reported a position in CBMG in Q1 2015 and held it in 1 quarter. The position peaked at $267K in Q1 2015. 45 funds tracked by Wall St. Rank hold CBMG as of Q2 2015.

  • Virtu KCG Holdings reported no remaining Cellular Biomedicine Group, Inc. position as of Q2 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 8,487 Cellular Biomedicine Group, Inc. shares in Q2 2015, an estimated $267K.
  • Virtu KCG Holdings first reported a position in Cellular Biomedicine Group, Inc. in Q1 2015 and held it in 1 quarter.
  • Virtu KCG Holdings's Cellular Biomedicine Group, Inc. position peaked at $267K in Q1 2015.
  • 45 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q2 2015.

Based on Virtu KCG Holdings's 13F filing for Q2 2015, filed 13 Aug 2015.